Donanemab (Genetical Recombination) as Active ingredient
1 - 1 of 1 results
for
Donanemab (Genetical Recombination)

- Medicine name
-
kisunla Intravenous Infusion 350mg
- Active ingredient
- Donanemab (Genetical Recombination)
- Manufacturer
- Eli Lilly Japan K.K.
- Category
- Agents affecting nervous system and sensory organs
Login required
- Filter by category:
- Agents affecting nervous system and sensory organs
- Filter by manufacturer:
- Eli Lilly Japan K.K.
- Filter by tag:
- Powerful drug
- Biological products